COLO-COHORT (Colorectal Cancer Cohort) Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSouth Tyneside and Sunderland NHS Foundation Trust
About this trial
This is a cross-sectional study aimed at identifying factors which best predicts patients at high risk of colorectal cancer or colorectal adenomas and to develop a risk prediction model.
Eligibility criteria
Qualifiers
Aged ≥30 years* and able to give informed consent
Patients attending colonoscopy
Through Bowel Cancer Screening Programme (FIT positive, Bowelscope conversion, surveillance)
Through standard NHS care (most commonly due to iron deficiency anaemia, altered bowel habit, weight loss, rectal bleeding, planned polypectomy**, those referred on basis of family history, abnormal cross-sectional imaging, polyp surveillance or post CRC surveillance)
Disqualifiers
Unable to give informed consent
Known polyposis syndrome
Previous total colectomy
Known colonic stricture which would limit complete colonoscopy
Trial design
Treatments tested in this trial
- Colonoscopy
Treatment groups
15,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
South Tyneside and Sunderland NHS Foundation Trust
Lead sponsor
Newcastle University
Collaborator
Source ClinicalTrials.gov